Ultragenyx Sees Prelim. FY19 Sales $102M-$104M vs 100.68M Est., Sees Prelim. FY19 Crysvita Sales $86M-$88M; Sees FY20 Crysvita Sales In Ultragenyx Territories $125M-$140M Excluding EU Royalty Revenue
Benzinga Newsdesk